CLINICAL CASE OF DIPHYLLOBOTHRIOSIS
Abstract
Diphyllobothriasis is one of the most common helminthiases in the Northern Hemisphere and in particular the Russian Federation (from 10 to 180 per 100 thousand population). Among the sick, adults and adolescents predominate, but cases of infection of young children have recently become more frequent. This publication presents a clinical case of diphyllobothriasis in a 3.5-year-old child, unrecognized at the primary stage of medical care. The described clinical case is an example of the fact that insufficient history taking and underestimation of general laboratory data can lead to delayed diagnosis and late initiation of antiparasitic therapy. There is also insufficient scientific evidence regarding the selection of a therapeutic dose of Praziquantel for children under 4 years of age. The purpose of the described case is to draw the attention of physicians (primary care and not only) to the thoroughness of taking an anamnesis (including epidemiological) and to the clinical interpretation of laboratory data in accordance with the existing clinical and epidemiological situation, to assist physicians in the treatment profile in selecting an adequate dose of Praziquantel in case of treatment of children under 4 years of age.
References
Государственный доклад Управления Роспотребнадзора по Республике Саха (Якутия). О состоянии санитарно-эпидемиологического благополучия населения в Республике Саха (Якутия) в 2020 году.
Аракельян Р.С., Аракелянц О.А., Кальчук А.В. и др. Клинические и эпидемиологические аспекты Дифиллоботриоза взрослых и детей. МНИЖ. 2022; 8: 122. DOI: 10.23670/IRJ.2022.122.20.
Александров П.А. Дифиллоботриоз — симптомы и лечение. Онлайн-энциклопедия «Про болезни». Доступен по: http:// https://probolezny.ru/difillobotrioz/ (дата обращения: 15.01.2023).
Баранов А.А., Володин Н.Н., Самсыгина Г.А. и др. Рациональная фармакотерапия детских заболеваний. Том 15. Книга 1. М.: Литтерра; 2007.
Воронцов И.М., Мазурин А.В. Пропедевтика детских болезней. Издание 3-е, дополненное и переработанное. СПб.: Фолиант; 2009.
Зеля О.П. Современная ситуация по дифиллоботриозу: эпидемиология и эпиднадзор. Медицинская паразитология и паразитарные болезни. 2017; 1: 52–9.
Корнакова Е.Е. Медицинская паразитология. М.: Academia. 2012.
Кривопустов С.П., Щербинская Е.Н., Логинова И.А. Гельминтозы в клинической педиатрии: вопросы диагностики, терапии, профилактики. Здоровье ребенка. 2011; 4(31): 71–5.
Козлов С.С., Сергиев В.П., Лобзин Ю.В. Паразитарные болезни человека (протозоозы и гельминтозы). СПб.: Фолиант; 2016.
Пшенникова Е.В., Ахременко Я.А., Николаева И.В., Захарова З.А. Показатели заболеваемости дифиллоботриозом населения республики Саха (Якутия). DOI: 10.25587/SVFU.2020.18.61535.
Храмцова Е.Г., Муравьева Н.Н., Клиорина Т.А., Акимов А.А. Длительный субфебрилитет в детском возрасте: современные аспекты диагностического поиска. Педиатр. 2013; 4(2): 97–105. DOI: 10.17816/PED4297-105.
Чебышев Н.В. Медицинская паразитология. Учебное пособие. М.: Медицина; 2012.
ChouH-F., YenC-M., LiangW-C., Jong Y-J. Diphyllobothriasislatum: the first child case report in Taiwan. 2006; DOI: 10.1016/S1607-551X(09)70321-3. Kaohsiung J Med Sci. 2006; 22(7): 346–51. PMID: 16849103.
Diphyllobothrium Infection — Centers for Disease Control and Prevention. [Электронный ресурс]. Дата обращения: 08.01.2023.
Lee S.H., Park H., Seung YuS.T. Diphyllobothriumlatum infection in a child with recurrent abdominal pain. 2015; 58(11): 451–3. DOI: 10.3345/kjp.2015.58.11.451.
Ncube M.V., Kabuyaya M., Chimbari M.J. Patient journey and resources mapping to implement a praziquantel mass drug administration program for children aged 5 years and below in resource-limited settings. 2022; 11(1): 227. DOI: 10.1186/s13643-022-02087-z.
Scholz T., Garcia H.H., Kuchta R., Wicht B. Update on the human broad tapeworm (genus diphyllobothrium), including clinical relevance. 2009; (1): 146–60. DOI: 10.1128/CMR.00033-08.
Zwang J., Olliaro P. Efficacy and safety of praziquantel 40 mg/kg in preschool-aged and school-aged children: a meta-analysis. 2017; 10(1): 47. DOI: 10.1186/s13071-016-1958-7.
Stothard J.R., Sousa-Figueiredo J.C, Betson M. et al. Closing the praziquantel treatment gap: new steps in epidemiological monitoring and control of schistosomiasis in African infants and preschool-aged children. 2011; (12): 1593–606. DOI: 10.1017/S0031182011001235.
REFERENCES
Gosudarstvennyy doklad Upravleniya Rospotrebnadzora po Respublike Sakha (Yakutiya). O sostoyanii sanitarno-epidemiologicheskogo blagopoluchiya naseleniya v Respublike Sakha (Yakutiya) v 2020 godu. [On the state of sanitary and epidemiological well-being of the population in the Republic of Sakha (Yakutia) in 2020]. (in Russian).
Arakel’yan R.S., Arakelyants O.A., Kal’chuk A.V. i dr. Klinicheskiye i epidemiologicheskiye aspekty Difillobotrioza vzroslykh i detey. [Clinical and epidemiological aspects of Diphyllobothriasis in adults and children] MNIZH. 2022; 8: 122. DOI: 10.23670/IRJ.2022.122.20. (in Russian).
Aleksandrov P.A. Diphyllobothriasis — symptoms and treatment. [Diphyllobothriasis — symptoms and treatment.] Online encyclopedia “Prodiseases”. Available at:http:// https://probolezny.ru/difillobotrioz/ (date of access: 01.15.2023). (in Russian).
Baranov A.A., Volodin N.N., Samsygina G.A. i dr. Racional’naya farmakoterapiya detskih zabolevanij. [Rational pharmacotherapy of children’s diseases]. Tom 15. Kniga 1. Moskva: Litterra Publ., 2007. (in Russian)
Voroncov I.M., Mazurin A.V. Propedevtika detskih boleznej. [Propaedeutics of childhood diseases]. Izdanie 3-e, dopolnennoe i pererabotannoe. Sankt-Peterburg: Foliant Publ.; 2009. (in Russian)
Zelja O.P. The current situation with diphyllobothriasis: epidemiology and surveillance. [The current situation with diphyllobothriasis: epidemiology and surveillance]. Medical parasitology and parasitic diseases. 2017; 1: 52–9. (in Russian).
Kornakova E.E. Medical parasitology. [Medical parasitology]. Moskva: Academia Publ.; 2012. (in Russian).
Krivopustov S.P., Shherbinskaja E.N., Loginova I.A. i dr. Helminthiases in clinical pediatrics: issues of diagnosis, therapy, prevention. [Helminthiases in clinical pediatrics: issues of diagnosis, therapy, prevention]. Child health. 2011; 4(31): 71–5. (in Russian).
Kozlov S.S., Sergiev V.P., Lobzin Ju.V. Human parasitic diseases (protozooses and helminthiases). [Parasitic human diseases (protozooses and helminthiases)]. Sankt-Peterburg: Foliant Publ.; 2016. (in Russian).
Pshennikova E.V., Ahremenko Ja.A., Nikolaeva I.V., Zaharova Z.A. Indicators of the incidence of diphyllobothriasis in the population of the Republic of Sakha (Yakutia). [Indicators of the incidence of diphyllobothriasis in the population of the Republic of Sakha (Yakutia)]. DOI: 10.25587/SVFU.2020.18.61535. UDK 616-093/-098. (in Russian).
Hramcova E.G., Murav’eva N.N., Kliorina T.A., Akimov A.A. Dlitel’nyj subfebrilitet v detskom vozraste: sovremennye aspekty diagnosticheskogo poiska. [Prolonged subfebrility in childhood: modern aspects of diagnostic search]. Pediatr. 2013; 4(2): 97–105. DOI: 10.17816/PED4297-105. (in Russian).
Chebyshev N.V. Medical parasitology. [Medical parasitology]. Tutorial. Moskva: Medicine Publ.; 2012. (in Russian).
ChouH-F., YenC-M., LiangW-C., Jong Y-J. Diphyllobothriasislatum: the first child case report in Taiwan. 2006; DOI: 10.1016/S1607-551X(09)70321-3. Kaohsiung J Med Sci. 2006; 22(7): 346–51. PMID: 16849103.
Diphyllobothrium Infection — Centers for Disease Control and Prevention. [Electronic resource]. Date of access: 08.01.2023.
Lee S.H., Park H., Seung YuS.T. Diphyllobothriumlatum infection in a child with recurrent abdominal pain. 2015; 58(11): 451–3. DOI: 10.3345/kjp.2015.58.11.451.
Ncube M.V., Kabuyaya M., Chimbari M.J. Patient journey and resources mapping to implement a praziquantel mass drug administration program for children aged 5 years and below in resource-limited settings. 2022; 11(1): 227. DOI: 10.1186/s13643-022-02087-z.
Scholz T., Garcia H.H., Kuchta R., Wicht B. Update on the human broad tapeworm (genus diphyllobothrium), including clinical relevance. 2009; (1): 146–60. DOI: 10.1128/CMR.00033-08.
Zwang J., Olliaro P. Efficacy and safety of praziquantel 40 mg/kg in preschool-aged and school-aged children: a meta-analysis. 2017; 10(1): 47. DOI: 10.1186/s13071-016-1958-7.
Stothard J.R., Sousa-Figueiredo J.C, Betson M. et al. Closing the praziquantel treatment gap: new steps in epidemiological monitoring and control of schistosomiasis in African infants and preschool-aged children. 2011; (12): 1593–606. DOI: 10.1017/S0031182011001235.
